Amanda Knox's future still hangs in limbo, but the 27-year-old, who was previously convicted of murdering her British roommate, is set to marry Brooklyn musician Colin Sutherland. Knox hasn't publicly shared the happy news but a source close to her confirmed the engagement to The Seattle Times.

According to the newspaper, Knox and Sutherland have known each other since middle school and he recently moved to the Seattle area from New York. People magazine reports that the two didn't start dating until Knox split from James Terrano last year.

Knox has tried to keep a low profile and piece her life back together after she was released from an Italian prison in 2011. The Seattle native and her ex-boyfriend, Raffaele Sollecito, were both sentenced to prison for the murder of Knox's roommate, Meredith Kercher. On Nov. 2, 2007, Kercher was found brutally murdered in the house she shared with Knox.

Sollecito and Knox, who was studying abroad in Italy, were found guilty in 2009 but were acquitted two years later. Upon returning to Seattle, Knox graduated with a bachelor's degree in creative writing from the University of Washington and started freelancing for the West Seattle Herald.

She's currently a local arts and human interest writer and also works at a bookstore, The Seattle Times reports.

"We approached her originally to give her the opportunity of a normal life," web editor Patrick Robinson previously told The Daily Beast. "We simply asked her as we would ask anyone of that age and stage, if they would be interested in writing for us as a qualified writer of that scale and this level of journalism."

"Amanda's very bright, very capable, highly qualified writer," Robinson continued. "She's certainly been through a lot and been very easy to work with and very interested and eager."

In Jan. 2014, Knox and her ex-boyfriend were re-convicted after prosecutors appealed the court's decision for acquittal. Next month, Knox will learn whether Italy's Court of Cassation will allow Italy to force her to return for another trial.